Xiaoqian Ma

机构：Central South University, Peking University, National Health and Family Planning Commission, Xenotran (United States), Biology of Infection, Peking University Third Hospital, Third Xiangya Hospital · ORCID：0000-0002-8315-9927

发表论文 195 篇 · 总被引 4696 次 · h-index 36

代表论文

Targeted delivery of CCL3 reprograms macrophage antigen presentation and enhances the efficacy of immune checkpoint blockade therapy in hepatocellular carcinoma (2025 · Journal for ImmunoTherapy of Cancer · 被引 23)
Bismuth/manganese-doped carbon dots in calcium phosphate matrix: Dynamic conformational nanoparticles enhancing tumor accumulation, deep penetration, and radiosensitivity (2024 · Chemical Engineering Journal · 被引 20)
Zinc-based radioenhancers to activate tumor radioimmunotherapy by PD-L1 and cGAS-STING pathway (2024 · Journal of Nanobiotechnology · 被引 16)
Natural variation in the Tn1a promoter regulates tillering in rice (2024 · Plant Biotechnology Journal · 被引 12)
HSA-templated synergistic platform boosts radiotherapy via enhanced radiosensitization and ferroptosis induction (2025 · Drug Resistance Updates · 被引 7)
A scientometric review of global research on solar photovoltaics and poverty alleviation (2024 · Environment Development and Sustainability · 被引 7)